FDA Whistleblower to Air New Pain Drug Analysis (Reuters)


Reuters - A veteran U.S. Food and Drug
Administration scientist will unveil new data on Thursday
before an expert panel charged with determining whether pain
relievers similar to Merck & Co. Inc.'s now-withdrawn Vioxx
should remain on the market.

Read more...